2025-08-29 03:24:22
Latest Post
Himadri Speciality Chemical Ltd Secures ISCC PLUS Certification
HCLSoftware delivers Digital Independence with AI-Powered Sovereign Collaboration Solutions for Business-Critical Infrastructure
Dr. Agarwal's Health Care Limited and Dr. Agarwal's Eye Hospital Limited announce Merger
SAMHI signs agreement to Lease for ~260-room Mid-Scale Hotel in Hyderabad's Financial District
Rail Vikas Nigam Ltd signs JV agreement with Texmaco Rail & Engineering Ltd
Stock Report
Emmessar Biotech and Nutrition Ltd Q2 FY2022-23 profit lower at Rs. 13.49 lakhs
Posted On : 2022-10-21 13:47:53( TIMEZONE : IST )
EMMESSAR BIOTECH & NUTRITION LTD. has reported Standalone financial results for the period ended September 30, 2022.
Financial Results (Q2 FY2023) - QoQ Comparison
The company has reported total income of Rs. 0.4998 crores during the period ended September 30, 2022 as compared to Rs. 0.6487 crores during the period ended June 30, 2022.
The company has posted net profit / (loss) of Rs. 0.1349 crores for the period ended September 30, 2022 as against net profit / (loss) of Rs. 0.1953 crores for the period ended June 30, 2022.
The company has reported EPS of Rs. 0.27 for the period ended September 30, 2022 as compared to Rs. 0.39 for the period ended June 30, 2022.
| Financials | Q2 FY2023 | Q1 FY2023 | % Change |
| Total Income | ₹ 0.4998 crs | ₹0.6487 crs |  -22.95% |
| Net Profit | ₹0.1349 crs | ₹0.1953 crs | -30.93% |
| EPS | ₹0.27 | ₹0.39 | -30.77% |
Financial Results (Q2 FY2023) - YoY Comparison
The company has reported total income of Rs. 0.4998 crores during the period ended September 30, 2022 as compared to Rs.0.4629 crores during the period ended September 30, 2021.
The company has posted net profit / (loss) of Rs.0.1349 crores for the period ended September 30, 2022 as against net profit / (loss) of Rs.0.1835 crores for the period ended September 30, 2021.
The company has reported EPS of Rs.0.27 for the period ended September 30, 2022 as compared to Rs.0.37 for the period ended September 30, 2021.
| Financials | Q2 FY2023 | Q2 FY2022 | % Change |
| Total Income | ₹ 0.4998 crs | ₹0.4629 crs |  7.97% |
| Net Profit | ₹0.1349 crs | ₹0.1835 crs | -26.49% |
| EPS | ₹0.27 | ₹0.37 | -27.03% |
Financial Results (Half Year Ended FY2023) - YoY Comparison
The company has reported total income of Rs.1.1485 crores during the 6 Months period ended September 30, 2022 as compared to Rs.0.8642 crores during the 6 Months period ended September 30, 2021.
The company has posted net profit / (loss) of Rs.0.3302 crores for the 6 Months period ended September 30, 2022 as against net profit / (loss) of Rs.0.2715 crores for the 6 Months period ended September 30, 2021.
The company has reported EPS of Rs.0.66 for the 6 Months period ended September 30, 2022 as compared to Rs.0.54 for the 6 Months period ended September 30, 2021.
| Financials | Half Year Ended FY2023 | Half Year Ended FY2022 | % Change |
| Total Income | ₹1.1485 crs | ₹0.8642 crs | 32.90% |
| Net Profit | ₹0.3302 crs | ₹0.2715 crs | 21.62% |
| EPS | ₹0.66 | ₹0.54 | 22.22% |
Shares of EMMESSAR BIOTECH & NUTRITION LTD. was last trading in BSE at Rs. 24.80 as compared to the previous close of Rs. 24.25. The total number of shares traded during the day was 3989 in over 50 trades.
The stock hit an intraday high of Rs. 25.45 and intraday low of 23.00. The net turnover during the day was Rs. 96758.00.
